Diabetes part 1.5 Flashcards

(40 cards)

1
Q

Age of Type 1 vs type 2

A

30 (unless children)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Onset of Type 1 vs type 2

A

Abrupt; Gradual

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Body of Type 1 vs type 2

A

Lean; Obese

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Insulin resistance type 1

A

Absent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Autoantibodies type 1

A

Often present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Weight loss at diagnosis type 1 vs. type 2

A

Common vs. uncommon

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ketones at diagnosis type 1 or type 2?

A

Type 1 present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Need for insulin therapy type 1 or type 2?

A

Type 1 needed immediate; type 2 years later

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Acute complications of type 1

A

diabetic ketoacidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

acute complications of type 2

A

hyperosmolar hyperglycemic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Microvascular complications at diagnosis?

A

Type 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Macrovascular complications?

A

Type 1 rare; type 2 common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Symptoms of type 1

A

polyuria, nocturia, polydipsia, polyphagia, weight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptoms of type 2

A

uncommon; lethargy, polyuria, nocturia, and polydipsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Screening normal adults

A

45 y.o. every 3 yrs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Screening adults BMI>25 or >23 Asian Americans with risk factors

A

Repeat at least every 3 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pediatric >10

A

BMI>85th percentile age and weight
Weight for height>85th percentile
weight>120% of IBW

Repeat every 3 years

18
Q

Risk factors of DM in adult populations

A

BMI>25 (>23 AsianAm)
Physical inactivity
First degree relative with DM
Member of high risk ethnic pop
Women delivered baby >9 lb or diagnosed with GDM
Hypertension BP>140/90
HDL250
Women with polycystic ovarian syndrome (PCOS)
Acanthosis nigricans
History CVD
a1c>5.7%, impaired glucose tolerance, impaired fasting

19
Q

Risk factors for pediatric

A

Family history of type 2 first/second degree relative
Member of high risk ethnic pop
Signs of insulin resistance (acanthosis nigricans, HTN, dyslipidemia, PCOS, small for gestational age birth weight
Maternal history of DM/ Gestational DM

20
Q

Fasting glucose to diagnose Type 2

A

BG>/= 126 mg/dL

21
Q

Increased risk of DM a1c range

22
Q

Goals of therapy

A

Reduce risk of micro/macro complications
Improve symptoms, quality of life, reduce mortality
Hemoglobin a1c <6

23
Q

Lifestyle changes

A

Medical Nutrition therapy (MNT)
Physical activity (150/week mod intensity 30 min x2)
Lose 5%-10% of weight
Bariatric surgery (BMI >35)
Limit alcohol intake 1 drink/day FM and 2/day M
Smoking cessation

24
Q

Biguanides

A

Metformin (Glucophage)

25
Acetohexamide
First Gen. Sulfonylureas
26
Chlorpropamide
First Gen. Sulfonylureas
27
Glimepiride
Second Gen
28
Glyburide
Second Gen
29
Tolazamide
First Gen
30
Glipizide
Second Gen
31
Tolbutamide
First Gen
32
mealtime bolus
fast onset, shorter duration
33
maintenance basal
slower onset, longer duration; provides appropriate levels b/t meals and during sleep inhibiting gluconeogenesis
34
premixed insulins
combine mealtime and maintenance both types of coverage in single product
35
Drug delivery by SC injection
Fatty layer between dermis and muscle. Relatively low blood flow - absorbed more slowly than IM
36
Typical volumes of SC
2 mL or less
37
Insulin absorption rates vary depending on site
Ab>arm>hip>thigh>buttock
38
Insulin pumps awesome
Rapid absorption; constantly monitor and correct patients glucose or insulin levels
39
formulation metaformin
IR, ER tabs and oral solution. ER use matrix-diffusion mechanism to slow rate of release
40
absorption metaformin
absorbed rapidly oral bio - 50-60% Take immediately after meal to prevent GI upset